Aging Promotes Pain Chronification through Changes in PGC-1alpha Expression and Interneuron Dysfunction
衰老通过 PGC-1α 表达的变化和中间神经元功能障碍促进疼痛慢性化
基本信息
- 批准号:10026358
- 负责人:
- 金额:$ 16.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-01 至 2022-05-31
- 项目状态:已结题
- 来源:
- 关键词:AdjuvantAdultAffectAgeAgingAmericanAnimalsApplications GrantsAreaArthritisAttentionBehaviorBehavioral AssayBiogenesisBiologicalC57BL/6 MouseCalciumCenters for Disease Control and Prevention (U.S.)Clinical ResearchDataDiabetes MellitusElderlyEmotionalExhibitsFunctional disorderFutureGrantHeart DiseasesImpaired cognitionImpairmentIndividualInflammatoryInflammatory ArthritisInflammatory ResponseInterneuron functionInterneuronsJointsMalignant NeoplasmsMediatingMental DepressionMitochondriaMolecularMolecular BiologyMood DisordersMorbidity - disease rateMusNeuronsNociceptionOutcomePainPain ResearchPathogenesisPopulationPre-Clinical ModelPrevalencePubMedQuality of lifeRattusReportingResearchRoleSomatosensory CortexTestingThermal Hyperalgesiasage groupagedankle jointarthritic paincalmodulin-dependent protein kinase IIchronic painclinically significantcomorbiditycostfrailtyfunctional declinehuman very old age (85+)inflammatory paininnovationinsightjuvenile animalmechanical allodyniamortalitymouse modelnociceptive responsenovelpre-clinicalsensorsomatosensorystemtherapeutic targettranslational studytwo photon microscopyyoung adult
项目摘要
Chronic pain affects millions of Americans and costs more than $635 billion yearly. The burden of chronic pain
is heavily tilted toward older adults. For example, the prevalence of chronic pain is 13.2% in adults 25-44 years
old, but 33.6% in population >85 years old. Pain in older adults not only negatively impacts quality of life,
increases frailty, but also is related with depression and cognitive decline. As such, studying chronic pain in older
individuals, particularly the pathogenesis of pain, the mechanisms behind pain chronification, and the comorbid
interactions between pain and other aging related issues is urgently warranted. Age, however, has largely been
ignored as a biological variable in preclinical pain research. In preliminary studies, we examined if pain in older
animals has unique features than that in younger animals. Specifically, we challenged animals with CFA to
induce arthritis, and examined nociceptive behavior in 2 months (young), 12 months (adult), and 25 months old
(aged) C57BL/6 mice. Results indicate that the same inflammatory insult in ankle joint led to significant
mechanical allodynia in all age groups. However, the duration of mechanical allodynia lasted for about 4 weeks,
4 weeks, and 7 weeks, in young, adult, and aged mice respectively. Thermal hyperalgesia in these animals
lasted about 3 weeks, 3.5 weeks, and 6 weeks, respectively. We ruled out unresolved joint inflammatory
responses as the cause of prolonged nociceptive responses in aged mice. It is therefore likely that aged animals
exhibited pain chronification associated with aging. Our lab has previously found that PGC-1, a master regulator
of mitochondria biogenesis, is implicated in pain chronification. More intriguingly, preliminary data also indicate
that aged mice expressed lower levels of PGC-1 in somatosensory cortex than their younger counterparts.
PGC-1 is preferentially expressed in, and critical for the function of, interneurons, whose dysfunction has been
associated with functional and cognitive decline in aging. As such, we hypothesize that aging is associated with
decreased somatosensory cortex PGC-1 levels, which impairs interneuron function and facilitates pain
chronification. We plan to carry out two Specific Aims to test this hypothesis. Aim 1: To examine the impact of
age on neuronal activities in pain. Aim 2: To study if pain chronification in aging can be ameliorated by increasing
PGC-1 levels in somatosensory cortex S1. Taken together, this R03 GEMMSTAR proposal aims at examining
age as a biological variable in pain, particularly in pain chronification associated with aging, in a preclinical model.
This is an area that has great clinical significance but has received little research attention to date. This grant is
innovative as it combines molecular biology, cutting edge intravital two-photon microscopy, and behavioral
assays to examine a key role for PGC-1 and interneuron in aging and pain chronification. Successful execution
of this grant will provide novel mechanistic insights into pain chronification associated with aging, to inform future
translational and clinical studies.
慢性疼痛会影响数百万美国人,每年成本超过6350亿美元。慢性疼痛的灼伤
大量倾斜到老年人。例如,慢性疼痛的患病率为13.2%,成人25 - 44年
年龄较大,但人口> 85岁。老年人的疼痛不仅会对生活质量产生负面影响
增加脆弱,但也与抑郁症和认知能力下降有关。因此,研究老年人的慢性疼痛
个体,尤其是疼痛的发病机理,疼痛回19的机制和合并症
迫切需要疼痛与其他与衰老有关的问题之间的相互作用。但是,年龄在很大程度上已经
在临床前疼痛研究中被忽略为生物变量。在初步研究中,我们检查了年龄较大的疼痛是否
动物具有独特的特征,而在年轻动物中具有独特的特征。具体来说,我们向CFA的动物挑战
诱导关节炎,并检查了2个月(年轻),12个月(成人)和25个月大的伤害性行为
(老年)C57BL/6小鼠。结果表明,踝关节中相同的炎症损伤导致显着
所有年龄段的机械异常性症。但是,机械性异常性疾病的持续时间持续了大约4周,
年轻,成人和老年小鼠分别为4周和7周。这些动物的热痛觉过敏
分别持续了大约3周,3.5周和6周。我们排除了未解决的关节炎症
反应是老年小鼠的长时间伤害性反应的原因。因此,老年动物很可能
表现出与衰老相关的疼痛回归。我们的实验室以前已经发现,主调节器PGC-1
线粒体生物发生,暗示在疼痛编年期中。更有趣的是,初步数据也表明
老年小鼠在体感皮层中的PGC-1水平低于年轻的小鼠。
PGC-1优选在中间神经元的功能中表达,并且其功能障碍一直是
与衰老的功能和认知能力下降有关。因此,我们假设衰老与
降低体感皮层PGC-1水平,会损害中间神经元的功能并促进疼痛
计算。我们计划执行两个特定的目的来检验这一假设。目标1:检查
目标2:研究是否可以通过增加来改善衰老中的疼痛状态
体感皮质S1中的PGC-1水平。综上所述,此R03 Gemmstar提案旨在检查
临床前模型中的年龄是疼痛的生物学变量,尤其是在与衰老相关的疼痛变化中。
这个领域具有很大的临床意义,但迄今为止很少受到研究的关注。这笔赠款是
创新,因为它结合了分子生物学,尖端插入式两光子显微镜和行为
检验PGC-1和中间神经元在衰老和疼痛编年期中的关键作用的测定。成功执行
这笔赠款将提供有关与衰老相关的疼痛变化的新型机械见解,以告知未来
翻译和临床研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Shiqian Shen其他文献
Shiqian Shen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Shiqian Shen', 18)}}的其他基金
Gut Microbiota Underlies the Heterogeneity of Aging Brain's Susceptibility to Postoperative Delirium
肠道微生物群是衰老大脑对术后谵妄易感性异质性的基础
- 批准号:
10297433 - 财政年份:2021
- 资助金额:
$ 16.8万 - 项目类别:
Microbiome Dysbiosis and Postoperative Delirium Pathogenesis
微生物群失调与术后谵妄发病机制
- 批准号:
10055132 - 财政年份:2020
- 资助金额:
$ 16.8万 - 项目类别:
Development and Validation of a Clinically Relevant Animal Pain Model
临床相关动物疼痛模型的开发和验证
- 批准号:
10460795 - 财政年份:2020
- 资助金额:
$ 16.8万 - 项目类别:
Aging Promotes Pain Chronification through Changes in PGC-1alpha Expression and Interneuron Dysfunction
衰老通过 PGC-1α 表达的变化和中间神经元功能障碍促进疼痛慢性化
- 批准号:
10250503 - 财政年份:2020
- 资助金额:
$ 16.8万 - 项目类别:
Gut Microbiota Influences Postoperative Cognitive Dysfunction through Indole-3-Propionic Acid
肠道微生物群通过吲哚-3-丙酸影响术后认知功能
- 批准号:
9759966 - 财政年份:2018
- 资助金额:
$ 16.8万 - 项目类别:
Gut Microbiota Influences Postoperative Cognitive Dysfunction through Indole-3-Propionic Acid
肠道微生物群通过吲哚-3-丙酸影响术后认知功能
- 批准号:
10475064 - 财政年份:2018
- 资助金额:
$ 16.8万 - 项目类别:
Administrative Supplement: Gut Microbiota Influences Postoperative Cognitive Dysfunction through Indole-3-Propionic Acid
行政补充:肠道微生物群通过吲哚-3-丙酸影响术后认知功能障碍
- 批准号:
10388931 - 财政年份:2018
- 资助金额:
$ 16.8万 - 项目类别:
Gut Microbiota Influences Postoperative Cognitive Dysfunction through Indole-3-Propionic Acid
肠道微生物群通过吲哚-3-丙酸影响术后认知功能
- 批准号:
10238041 - 财政年份:2018
- 资助金额:
$ 16.8万 - 项目类别:
相似国自然基金
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
儿童期受虐经历影响成年人群幸福感:行为、神经机制与干预研究
- 批准号:32371121
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
依恋相关情景模拟对成人依恋安全感的影响及机制
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
依恋相关情景模拟对成人依恋安全感的影响及机制
- 批准号:32200888
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
生活方式及遗传背景对成人不同生命阶段寿命及死亡的影响及机制的队列研究
- 批准号:82173590
- 批准年份:2021
- 资助金额:56.00 万元
- 项目类别:面上项目
相似海外基金
Adult human brain tissue cultures to study neuroHIV
成人脑组织培养研究神经艾滋病毒
- 批准号:
10619170 - 财政年份:2023
- 资助金额:
$ 16.8万 - 项目类别:
Anti-flavivirus B cell response analysis to aid vaccine design
抗黄病毒 B 细胞反应分析有助于疫苗设计
- 批准号:
10636329 - 财政年份:2023
- 资助金额:
$ 16.8万 - 项目类别:
Effects of deep brain stimulation (DBS) on laryngeal function and associated behaviors in Parkinson Disease
深部脑刺激(DBS)对帕金森病喉功能和相关行为的影响
- 批准号:
10735930 - 财政年份:2023
- 资助金额:
$ 16.8万 - 项目类别:
Design of a Novel Nanocarrier Technology to Drug-Load CAR T cells
用于载药 CAR T 细胞的新型纳米载体技术的设计
- 批准号:
10734365 - 财政年份:2023
- 资助金额:
$ 16.8万 - 项目类别:
Preclinical assessment of a novel systemic drug candidate for osteoarthritic pain
治疗骨关节炎疼痛的新型全身候选药物的临床前评估
- 批准号:
10642544 - 财政年份:2023
- 资助金额:
$ 16.8万 - 项目类别: